Head Office +91 8729085230

Guru Angad Nagar,
New Delhi 110092

09.00 to 18.00 Monday to Saturday

Market Outlook:

Global Veterinary Injectable Devices market is expected to offer an $ opportunity of USD 467.15 million over the analysis period. i.e. 2022-2035. 

Veterinary Injectable Devices Market size is projected to be valued USD 1,463.6 Million by the end of 2035, growing at a CAGR of 5.14% during the analysis period, i.e., 2022 – 2035. In the base year (2022), the market size of Veterinary Injectable Devices was nearly USD 996.5 Million.

Base Year2022
Forecast Year2024-2035
CAGR5.14%
Base Year Market Size (2022)USD 996.5 Million
Forecast Year Market Size (2035)USD 1,463.6 Million

Market Insights:

Pet population is increasing across the globe, which is one of the animal categories required great attention from owner. There are approximately more than 450 pet dogs globally. Nearly 72% of U.S. households (90.5 million homes) owned a pet as of 2022. Brazil is having highest number of small dogs per capita in the world.  This number is likely to rise further across the globe. Cattle population amounted to about over 900 million. All these types of animals not immune to continues rise in the infectious disease, which is in turn need immediate treatment. 

As the veterinary hospitals and clinics prefer the fast on-set of action to get better response. Healthcare Professionals also expect these injectable devices need to be auto usable, convenient during application and accompanied with advanced technology. 

Recently launched injectable devices comes with lots of advancements, and usually preferred by veterinarians in hospitals and clinics, though unmet need still persist in the market. Several types of care need to be taken while giving injections, they applied through different routes, such as intramuscular, subcutaneous, and intravenous.

Market Dynamics:

Growth Drivers: Though there are the various factors responsible for the growth of veterinary injectable few of the leading one is depicted below:

  • Surging Demand for Animal Health – The attention on animal health and well-being has led to a rise in demand for animal healthcare, which encompasses the utilization of injectable products. Animal owner is currently, sending too much in health and food supplements. Our analysis revealed that, they always fear the susceptible infections, the animal might get therefore they also relied on prophylactic immunization. Several players currently playing significant role in improving animal health such as Zoetis has the largest share in the animal healthcare industry. Boehringer Ingelheim another leading one having almost 9.32% share of the industry.
  • Proliferation of Advancements Technology 
  • Rising cases of Zoonotic Disorders 
  • Growing Demand for Vaccine Immunization in the Wake of Pandemic
  • Launches of Technological Advanced Products: For instance, BD introduces BD SoloShot™ IX, a low-cost auto-disable injection device for immunization

Challenges Associated with Market:

  • Stringent Regulatory Supplies with Regard to Drugs
  • Lack of Awareness about animal care 
  • Complications associated with injections such as needle injuries, hypersensitivity reactions

Regional Market Outlook:

North America Market: North America market is expected to account for around 36.38% share in the global market. Being the largest market, it also attributable for the developments of new injectable devices, people already aware about animal care and spend lot of money on animal care. United States is largest market in the region accounting for more than 90% of share. Surging pet adoption, rising awareness, vaccines drive, growing per capital animal spending among others are the various factors contributing to the market growth of veterinary injectable devices.

Asia-Pacific is a lucrative market due to growing number of activities in the region accompanied with huge investments from market players. Country such as China, India, Japan and other are driving the overall market. Region is expected to grow at a highest CAGR % during the analysis period. Various countries government initiatives expected to boost the market statistics.

Strategic Market Insights: 

Report has covered the below pointers in details

  • Controlled release of drugs is a research area provide numerous benefits in veterinary drugs. Topics devices such as various collars, ear tags and, as well as some topically administered bioavailable delivery systems products are available in the market
  • Developments of Automatic Syringe for Farm Animals Vaccination
  • Opportunity in disposable and reusable drug delivery systems

Market Segmentation:

Our in-depth analysis of the Global Veterinary Injectable Devices Market includes the following segments:

Global Veterinary Injectable Devices Market
Base Year:2022Forecast Period:2024-2035
Historical Data:2020 to 2022Market Size in 2022:USD 996.5 Million
Forecast Period 2024-35 CAGR:5.14%Market Size in 2035:USD 1,463.6 Million
Segments Covered:By Product

 

  • Syringes
  • Needles
  • Remote Drug Delivery System
    • Darts
    • Pole Syringe
  • Needle Free Injection System
    • Spring loader jet injector
    • Battery powered jet injector
    • Gas powered jet injector
By Usability
  • Disposable
  • Re-Usable
By Material
  • Glass
  • Metal
  • Plastic
By End User
  • Veterinary Hospitals
  • Veterinary Clinics
By Region
  • North America (U.S., Canada)
  • Europe (United Kingdom, Germany, France, Italy, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Rest of APAC)
  • Middle East & Africa (Saudi Arabia, Israel, UAE, South Africa, Rest of MEA)
  • South America (Brazil, Mexico, Argentina, Rest of South America)
Key Market Drivers:
  • Surging Demand for Animal Health
  • Rising cases of Zoonotic Disorders  
Key Market Restraints:
  • Complications associated with needle insertion
Key Trends:
  • New product launches and investment
Companies Covered in the Report:
  • Röchling Medical
  • Boehringer Ingelheim International GmbH
  • Henke-Sass, Wolf GmbH
  • TeleDart USA
  • H.Hauptner and Richard Herberholz GmbH & Co. KG
  • Schippers Export BV
  • Hamilton Company
  • Allflex USA, Inc.
  • MSD
  • Praxisdienst
  • NEOGEN Corporation
  • Quick Shot Corporation
  • Terumo Medical Corporation
  • Other Major Players

Recent Developments in the Market:

  • NEOGEN Corporation announced that the company had acquired the companion animal health company, CAPInnoVet, Inc. The acquisition would help NEOGEN to expand its portfolio in pet medications to the veterinary market.
  • Boehringer Ingelheim announced that its intramuscular needle-free device, FreVAX, can now be managed with the new version of FreVAX smartphone app.